Clinical Trial Update: Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer [Phase 2]

View source ↗

Summary

Clinical trial update indicates termination of a Phase 2 study combining chemotherapy and interferon alfa followed by surgery and/or radiation for stage I–III e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Chemotherapy (unspecified agents)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Northwestern University | Conditions: Esophageal Cancer | Phase 2 | Status: TERMINATED